These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 17895322)

  • 1. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
    Goldfine AB; Mun EC; Devine E; Bernier R; Baz-Hecht M; Jones DB; Schneider BE; Holst JJ; Patti ME
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4678-85. PubMed ID: 17895322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery.
    McLaughlin T; Peck M; Holst J; Deacon C
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1851-5. PubMed ID: 20133462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More symptoms but similar blood glucose curve after oral carbohydrate provocation in patients with a history of hypoglycemia-like symptoms compared to asymptomatic patients after Roux-en-Y gastric bypass.
    Laurenius A; Werling M; Le Roux CW; Fändriks L; Olbers T
    Surg Obes Relat Dis; 2014; 10(6):1047-54. PubMed ID: 25205571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
    Salehi M; Gastaldelli A; D'Alessio DA
    Gastroenterology; 2014 Mar; 146(3):669-680.e2. PubMed ID: 24315990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Hormonal Response to a Mixed-Meal Challenge in Hypoglycemia After Sleeve Gastrectomy vs Gastric Bypass.
    Lee CJ; Clark JM; Egan JM; Carlson OD; Schweitzer M; Langan S; Brown T
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4159-e4166. PubMed ID: 35914520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia.
    Lee CJ; Brown T; Magnuson TH; Egan JM; Carlson O; Elahi D
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1208-12. PubMed ID: 23666968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
    Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
    Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.
    Vidal J; Nicolau J; Romero F; Casamitjana R; Momblan D; Conget I; Morínigo R; Lacy AM
    J Clin Endocrinol Metab; 2009 Mar; 94(3):884-91. PubMed ID: 19106269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update.
    Øhrstrøm CC; Worm D; Hansen DL
    Surg Obes Relat Dis; 2017 Feb; 13(2):345-351. PubMed ID: 27865808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.
    Falkén Y; Hellström PM; Holst JJ; Näslund E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2227-35. PubMed ID: 21543426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
    Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
    Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia.
    Salehi M; Gastaldelli A; D'Alessio DA
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2008-17. PubMed ID: 24617664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.
    Nguyen NQ; Debreceni TL; Bambrick JE; Chia B; Wishart J; Deane AM; Rayner CK; Horowitz M; Young RL
    J Clin Endocrinol Metab; 2015 Mar; 100(3):968-76. PubMed ID: 25423571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls.
    Wölnerhanssen BK; Meyer-Gerspach AC; Peters T; Beglinger C; Peterli R
    Surg Obes Relat Dis; 2016 Aug; 12(7):1320-1327. PubMed ID: 27012873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
    Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
    Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.